Manufactures and sells veterinary vaccines, mainly for livestock, to farmers, local governments and distributors.
20-F for FY2025, filed Apr 28, 2026We, through the operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on…View ↗
The operating entity has two types of customers, (i) direct-end user customers, including livestock farmers and local governments; and (ii)…View ↗
The operating entity generates revenue through manufacturing and sales of veterinary vaccines under its own brand. For the fiscal years…View ↗
The company sells veterinary vaccines; distributors pay before delivery, and sales are counted when customers accept the goods.
20-F for FY2025, filed Apr 28, 2026
CNY 116.4M
20-F for FY2025, filed Apr 28, 2026
CNY 116.4M ↗| Segment | Share | Revenue |
|---|---|---|
|
Swine vaccines
|
77% |
Swine vaccines, FY2025
$12.9M Sources
|
|
Poultry vaccines
|
11% |
Poultry vaccines, FY2025
$1.8M Sources
|
|
Other vaccines
|
12% |
Other vaccines, FY2025
$2M Sources
|
|
Direct sales channel
|
45%
FY2022: 80%
|
Direct sales channel, FY2025
$7.4M Sources
|
|
Distribution network
|
53%
FY2022: 18%
|
Distribution network, FY2025
$8.8M Sources
|
|
Government tender and procurement
|
2.5%
FY2022: 2.0%
|
Government tender and procurement, FY2025
$423K Sources
|
Livestock farmers and local governments buy directly, while domestic and overseas distributors resell the vaccines. Direct sales also reach major breeding companies through tenders and contracts with breeders.
20-F for FY2025, filed Apr 28, 2026The operating entity has two types of customers, (i) direct-end user customers, including livestock farmers and local governments; and (ii)…View ↗
Direct Sales ChannelView ↗
The operating entity’s domestic distributors cover 29 provincial-level administrative regions of the PRC for the resale of the operating…View ↗
The operating entity’s exporting distributors are local distributors in their respective countries. Through the efforts of these exporting…View ↗
20-F for FY2025, filed Apr 28, 2026
For the fiscal year ended December 31, 2025, MYF accounted for 13.7% of our total revenue. For the fiscal year ended December 31, 2024, MYF…View ↗
Not on paper. It lost CNY 69.8M in FY2025, but brought in more cash than it spent: CNY 12.3M of free cash flow.
Loading...